| 190 |
10.1001/jamaoncol.2017.2925 |
Association Of Immune-Related Adverse Events With
Nivolumab Efficacy In Non<U+2013>Small-Cell Lung Cancer |
Haratani, Koji; Hayashi, Hidetoshi; Chiba, Yasutaka;
Kudo, Keita; Yonesaka, Kimio; Kato, Ryoji; Kaneda, Hiroyasu; Hasegawa,
Yoshikazu; Tanaka, Kaoru; Takeda, Masayuki; Nakagawa, Kazuhiko |
Jama Oncology |
2018 |
| 200 |
10.1001/jamaoncol.2018.4514 |
Survival Outcomes In Patients With Previously Untreated
Braf Wild-Type Advanced Melanoma Treated With Nivolumab Therapy |
Ascierto, Paolo A.; Long, Georgina V.; Robert,
Caroline; Brady, Benjamin; Dutriaux, Caroline; Di Giacomo, Anna Maria;
Mortier, Laurent; Hassel, Jessica C.; Rutkowski, Piotr; Mcneil,
Catriona; Kalinka-Warzocha, Ewa; Savage, Kerry J.; Hernberg, Micaela M.;
Lebbe, Celeste; Charles, Julie; Mihalcioiu, Catalin; Chiarion-Sileni,
Vanna; Mauch, Cornelia; Cognetti, Francesco; Ny, Lars; Arance, Ana;
Svane, Inge Marie; Schadendorf, Dirk; Gogas, Helen; Saci, Abdel; Jiang,
Joel; Rizzo, Jasmine; Atkinson, Victoria |
Jama Oncology |
2019 |
| 205 |
10.1001/jamaoncol.2018.5860 |
Profiling Preexisting Antibodies In Patients Treated
With Anti<U+2013>Pd-1 Therapy For Advanced Non<U+2013>Small
Cell Lung Cancer |
Toi, Yukihiro; Sugawara, Shunichi; Sugisaka, Jun; Ono,
Hirotaka; Kawashima, Yosuke; Aiba, Tomoiki; Kawana, Sachiko; Saito,
Ryohei; Aso, Mari; Tsurumi, Kyoji; Suzuki, Kana; Shimizu, Hisashi;
Domeki, Yutaka; Terayama, Keisuke; Nakamura, Atsushi; Yamanda, Shinsuke;
Kimura, Yuichiro; Honda, Yoshihiro |
Jama Oncology |
2019 |
| 211 |
10.1001/jamaoncol.2019.0402 |
Association Of Checkpoint
Inhibitor<U+2013>Induced Toxic Effects With Shared Cancer And
Tissue Antigens In Non<U+2013>Small Cell Lung Cancer |
Berner, Fiamma; Bomze, David; Diem, Stefan; Ali, Omar
Hasan; Fassler, Mirjam; Ring, Sandra; Niederer, Rebekka; Ackermann,
Christoph J.; Baumgaertner, Petra; Pikor, Natalia; Cruz, Cristina Gil;
Van De Veen, Willem; Akdis, Mubeccel; Nikolaev, Sergey; Laubli, Heinz;
Zippelius, Alfred; Hartmann, Fabienne; Cheng, Hung-Wei; Honger, Gideon;
Recher, Mike; Goldman, Jonathan; Cozzio, Antonio; Fruh, Martin; Neefjes,
Jacques; Driessen, Christoph; Ludewig, Burkhard; Hegazy, Ahmed N.;
Jochum, Wolfram; Speiser, Daniel E.; Flatz, Lukas |
Jama Oncology |
2019 |
| 219 |
10.1001/jamaoncol.2019.5570 |
Association Between Immune-Related Adverse Events And
Recurrence-Free Survival Among Patients With Stage Iii Melanoma
Randomized To Receive Pembrolizumab Or Placebo |
Eggermont, Alexander M. M.; Kicinski, Michal; Blank,
Christian U.; Mandala, Mario; Long, Georgina V.; Atkinson, Victoria;
Dalle, Stephane; Haydon, Andrew; Khattak, Adnan; Carlino, Matteo S.;
Sandhu, Shahneen; Larkin, James; Puig, Susana; Ascierto, Paolo A.;
Rutkowski, Piotr; Schadendorf, Dirk; Koornstra, Rutger; Hernandez-Aya,
Leonel; Di Giacomo, Anna Maria; Van Den Eertwegh, Alfonsus J. M.; Grob,
Jean-Jacques; Gutzmer, Ralf; Jamal, Rahima; Lorigan, Paul C.; Krepler,
Clemens; Ibrahim, Nageatte; Marreaud, Sandrine; Van Akkooi, Alexander;
Robert, Caroline; Suciu, Stefan |
Jama Oncology |
2020 |
| 2525 |
10.1007/s00432-018-2805-3 |
Impact Of Immune-Related Adverse Events On Survival In
Patients With Advanced Non-Small Cell Lung Cancer Treated With
Nivolumab: Long-Term Outcomes From A Multi-Institutional Analysis |
Ricciuti, Biagio, 0000-0002-0651-2678; Genova, Carlo;
De Giglio, Andrea; Bassanelli, Maria; Dal Bello, Maria Giovanna; Metro,
Giulio; Brambilla, Marta; Baglivo, Sara; Grossi, Francesco; Chiari,
Rita |
Journal Of Cancer Research And Clinical Oncology |
2018 |
| 2526 |
10.1007/s00432-018-2819-x |
Immune-Related Adverse Events Correlate With Improved
Survival In Patients Undergoing Anti-Pd1 Immunotherapy For Metastatic
Melanoma |
Indini, Alice, 0000-0001-8686-4106; Di Guardo, Lorenza;
Cimminiello, Carolina; Prisciandaro, Michele; Randon, Giovanni; De
Braud, Filippo; Del Vecchio, Michele |
Journal Of Cancer Research And Clinical Oncology |
2018 |
| 4889 |
10.1016/j.clinthera.2018.11.004 |
Association Between Immune-Related Adverse Events And
Clinical Efficacy In Patients With Melanoma Treated With Nivolumab: A
Multicenter Retrospective Study |
Okada, Naoto; Kawazoe, Hitoshi, 0000-0003-1591-4051;
Takechi, Kenshi; Matsudate, Yoshihiro; Utsunomiya, Ryo; Zamami, Yoshito,
0000-0002-7879-423X; Goda, Mitsuhiro; Imanishi, Masaki; Chuma, Masayuki;
Hidaka, Noriaki; Sayama, Koji; Kubo, Yoshiaki; Tanaka, Akihiro;
Ishizawa, Keisuke |
Clinical Therapeutics |
2019 |
| 4890 |
10.1016/j.cllc.2018.10.002 |
Association Between Immune-Related Adverse Events And
Efficacy Of Immune Checkpoint Inhibitors In Non<U+2013>Small-Cell
Lung Cancer |
Grangeon, Mathieu; Tomasini, Pascale; Chaleat, Solene;
Jeanson, Arnaud; Souquet-Bressand, Maxime; Khobta, Nataliya; Bermudez,
Julien; Trigui, Youssef; Greillier, Laurent; Blanchon, Marilyne;
Boucekine, Mohamed; Mascaux, Celine; Barlesi, Fabrice |
Clinical Lung Cancer |
2019 |
| 4891 |
10.1016/j.cllc.2019.02.006 |
Correlations Between The Immune-Related Adverse Events
Spectrum And Efficacy Of Anti-Pd1 Immunotherapy In Nsclc Patients |
Cortellini, Alessio, 0000-0002-1209-5735; Chiari, Rita;
Ricciuti, Biagio, 0000-0002-0651-2678; Metro, Giulio,
0000-0002-4978-9212; Perrone, Fabiana; Tiseo, Marcello; Bersanelli,
Melissa; Bordi, Paola; Santini, Daniele; Giusti, Raffaele,
0000-0003-4592-8868; Grassadonia, Antonino; Di Marino, Pietro; Tinari,
Nicola; De Tursi, Michele; Zoratto, Federica; Veltri, Enzo; Malorgio,
Francesco; Garufi, Carlo; Russano, Marco; Anesi, Cecilia; Zeppola, Tea;
Filetti, Marco, 0000-0002-4734-7541; Marchetti, Paolo; Berardi, Rossana;
Rinaldi, Silvia; Tudini, Marianna; Silva, Rosa Rita; Pireddu,
Annagrazia; Atzori, Francesco; Iacono, Daniela; Migliorino, Maria Rita;
Porzio, Giampiero; Cannita, Katia; Ficorella, Corrado; Buti, Sebastiano,
0000-0003-0876-0226 |
Clinical Lung Cancer |
2019 |
| 5448 |
10.1016/j.ejca.2018.10.014 |
Immune-Related Adverse Events Predict The Therapeutic
Efficacy Of Anti<U+2013>Pd-1 Antibodies In Cancer Patients |
Rogado, J.; Sanchez-Torres, J.M.; Romero-Laorden, N.;
Ballesteros, A.I.; Pacheco-Barcia, V.; Ramos-Levi, A.; Arranz, R.;
Lorenzo, A.; Gullon, P.; Donnay, O.; Adrados, M.; Costas, P.; Aspa, J.;
Alfranca, A.; Mondejar, R.; Colomer, R., 0000-0002-6393-3444 |
European Journal Of Cancer |
2019 |
| 5456 |
10.1016/j.ejca.2019.07.001 |
Adjuvant Ipilimumab Versus Placebo After Complete
Resection Of Stage Iii Melanoma: Long-Term Follow-Up Results Of The
European Organisation For Research And Treatment Of Cancer 18071
Double-Blind Phase 3 Randomised Trial |
Eggermont, Alexander M.M.; Chiarion-Sileni, Vanna;
Grob, Jean-Jacques, 0000-0002-1014-4062; Dummer, Reinhard; Wolchok, Jedd
D.; Schmidt, Henrik; Hamid, Omid; Robert, Caroline; Ascierto, Paolo
Antonio, 0000-0002-8322-475X; Richards, Jon M.; Lebbe, Celeste;
Ferraresi, Virginia; Smylie, Michael; Weber, Jeffrey S.; Maio, Michele;
Hosein, Fareeda; De Pril, Veerle; Kicinski, Michal; Suciu, Stefan;
Testori, Alessandro |
European Journal Of Cancer |
2019 |
| 5459 |
10.1016/j.ejca.2019.11.016 |
Update On Tolerability And Overall Survival In
Columbus: Landmark Analysis Of A Randomised Phase 3 Trial Of Encorafenib
Plus Binimetinib Vs Vemurafenib Or Encorafenib In Patients With Braf
V600<U+2013>Mutant Melanoma |
Ascierto, Paolo A.; Dummer, Reinhard; Gogas, Helen J.;
Flaherty, Keith T.; Arance, Ana; Mandala, Mario; Liszkay, Gabriella;
Garbe, Claus; Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; De
Groot, Jan Willem B.; Loquai, Carmen; Gollerkeri, Ashwin; Pickard,
Michael D.; Robert, Caroline |
European Journal Of Cancer |
2020 |
| 10166 |
10.1016/s0140-6736(20)30417-7 |
Adjuvant Nivolumab Plus Ipilimumab Or Nivolumab
Monotherapy Versus Placebo In Patients With Resected Stage Iv Melanoma
With No Evidence Of Disease (Immuned): A Randomised, Double-Blind,
Placebo-Controlled, Phase 2 Trial |
Zimmer, Lisa; Livingstone, Elisabeth; Hassel, Jessica
C; Fluck, Michael; Eigentler, Thomas; Loquai, Carmen; Haferkamp,
Sebastian; Gutzmer, Ralf; Meier, Friedegund; Mohr, Peter; Hauschild,
Axel; Schilling, Bastian; Menzer, Christian; Kieker, Felix; Dippel,
Edgar; Rosch, Alexander; Simon, Jan-Christoph; Conrad, Beate; Korner,
Silvia; Windemuth-Kieselbach, Christine; Schwarz, Leonora; Garbe, Claus;
Becker, Jurgen C; Schadendorf, Dirk; Berking, Carola; Herbst, Rudolf A;
Martens, Uwe M; Sell, Sabine; Stadler, Rudolf; Terheyden, Patrick;
Utikal, Jochen |
The Lancet |
2020 |
| 10180 |
10.1016/s0140-6736(20)30934-x |
Atezolizumab, Vemurafenib, And Cobimetinib As
First-Line Treatment For Unresectable Advanced Brafv600
Mutation-Positive Melanoma (Imspire150): Primary Analysis Of The
Randomised, Double-Blind, Placebo-Controlled, Phase 3 Trial |
Gutzmer, Ralf; Stroyakovskiy, Daniil; Gogas, Helen;
Robert, Caroline; Lewis, Karl; Protsenko, Svetlana; Pereira, Rodrigo P;
Eigentler, Thomas; Rutkowski, Piotr; Demidov, Lev; Manikhas, Georgy
Moiseevich; Yan, Yibing; Huang, Kuan-Chieh; Uyei, Anne; Mcnally,
Virginia; Mcarthur, Grant A; Ascierto, Paolo A |
The Lancet |
2020 |
| 10250 |
10.1016/s1470-2045(18)30142-6 |
Encorafenib Plus Binimetinib Versus Vemurafenib Or
Encorafenib In Patients With Braf -Mutant Melanoma (Columbus): A
Multicentre, Open-Label, Randomised Phase 3 Trial |
Dummer, Reinhard; Ascierto, Paolo A; Gogas, Helen J;
Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus;
Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion-Sileni,
Vanna; Dutriaux, Caroline; De Groot, Jan Willem B; Yamazaki, Naoya;
Loquai, Carmen; Moutouh-De Parseval, Laure A; Pickard, Michael D;
Sandor, Victor; Robert, Caroline; Flaherty, Keith T |
The Lancet Oncology |
2018 |
| 10260 |
10.1016/s1470-2045(18)30497-2 |
Overall Survival In Patients With Braf-Mutant Melanoma
Receiving Encorafenib Plus Binimetinib Versus Vemurafenib Or Encorafenib
(Columbus): A Multicentre, Open-Label, Randomised, Phase 3 Trial |
Dummer, Reinhard; Ascierto, Paolo A; Gogas, Helen J;
Arance, Ana; Mandala, Mario; Liszkay, Gabriella; Garbe, Claus;
Schadendorf, Dirk; Krajsova, Ivana; Gutzmer, Ralf; Chiarion Sileni,
Vanna; Dutriaux, Caroline; De Groot, Jan Willem B; Yamazaki, Naoya;
Loquai, Carmen; Moutouh-De Parseval, Laure A; Pickard, Michael D;
Sandor, Victor; Robert, Caroline; Flaherty, Keith T |
The Lancet Oncology |
2018 |
| 10287 |
10.1016/s1470-2045(19)30151-2 |
Identification Of The Optimal Combination Dosing
Schedule Of Neoadjuvant Ipilimumab Plus Nivolumab In Macroscopic Stage
Iii Melanoma (Opacin-Neo): A Multicentre, Phase 2, Randomised,
Controlled Trial |
Rozeman, Elisa A; Menzies, Alexander M; Van Akkooi,
Alexander C J; Adhikari, Chandra; Bierman, Carolien; Van De Wiel, Bart
A; Scolyer, Richard A; Krijgsman, Oscar; Sikorska, Karolina; Eriksson,
Hanna; Broeks, Annegien; Van Thienen, Johannes V; Guminski, Alexander D;
Acosta, Alex Torres; Ter Meulen, Sylvia; Koenen, Anne Miek; Bosch, Linda
J W; Shannon, Kerwin; Pronk, Loes M; Gonzalez, Maria; Ch’Ng, Sydney;
Grijpink-Ongering, Lindsay G; Stretch, Jonathan; Heijmink, Stijn; Van
Tinteren, Harm; Haanen, John B A G; Nieweg, Omgo E; Klop, Willem M C;
Zuur, Charlotte L; Saw, Robyn P M; Van Houdt, Winan J; Peeper, Daniel S;
Spillane, Andrew J; Hansson, Johan; Schumacher, Ton N; Long, Georgina V;
Blank, Christian U |
The Lancet Oncology |
2019 |
| 10292 |
10.1016/s1470-2045(19)30331-6 |
Neoadjuvant Dabrafenib Combined With Trametinib For
Resectable, Stage Iiib<U+2013>C, Brafv600 Mutation-Positive
Melanoma (Neocombi): A Single-Arm, Open-Label, Single-Centre, Phase 2
Trial |
Long, Georgina V; Saw, Robyn P M; Lo, Serigne; Nieweg,
Omgo E; Shannon, Kerwin F; Gonzalez, Maria; Guminski, Alexander; Lee,
Jenny H; Lee, Hansol; Ferguson, Peter M; Rawson, Robert V; Wilmott,
James S; Thompson, John F; Kefford, Richard F; Ch’Ng, Sydney; Stretch,
Jonathan R; Emmett, Louise; Kapoor, Rony; Rizos, Helen; Spillane, Andrew
J; Scolyer, Richard A; Menzies, Alexander M |
The Lancet Oncology |
2019 |
| 10293 |
10.1016/s1470-2045(19)30332-8 |
Neoadjuvant Systemic Therapy In Melanoma:
Recommendations Of The International Neoadjuvant Melanoma
Consortium |
Amaria, Rodabe N; Menzies, Alexander M; Burton,
Elizabeth M; Scolyer, Richard A; Tetzlaff, Michael T; Antdbacka, Robert;
Ariyan, Charlotte; Bassett, Roland; Carter, Brett; Daud, Adil; Faries,
Mark; Fecher, Leslie A; Flaherty, Keith T; Gershenwald, Jeffrey E;
Hamid, Omid; Hong, Angela; Kirkwood, John M; Lo, Serigne; Margolin, Kim;
Messina, Jane; Postow, Michael A; Rizos, Helen; Ross, Merrick I;
Rozeman, Elisa A; Saw, Robyn P M; Sondak, Vernon; Sullivan, Ryan J;
Taube, Janis M; Thompson, John F; Van De Wiel, Bart A; Eggermont,
Alexander M; Davies, Michael A; Ascierto, Paolo A; Spillane, Andrew J;
Van Akkooi, Alexander C J; Wargo, Jennifer A; Blank, Christian U; Tawbi,
Hussein A; Long, Georgina V; Andrews, Miles C; Berry, Donald A; Block,
Matthew S; Boland, Genevieve M; Bollin, Kathryn B; Carlino, Matteo S;
Carvajal, Richard D; Cohen, Jonathan; Davar, Diwakar; Delman, Keith A;
Dummer, Reinhard; Farwell, Michael D; Fisher, David E; Fusi, Alberto;
Glitza, Isabella C; De Gruijl, Tanja D; Gyorki, David E; Hauschild,
Axel; Hieken, Tina J; Larkin, James; Lawson, David H; Lebbe, Celeste;
Lee, Jeffrey E; Lowe, Michael C; Luke, Jason J; Mcarthur, Grant A;
Mcdermott, David F; Mcquade, Jennifer L; Mitchell, Tara C; Petrella,
Teresa M; Prieto, Peter A; Puzanov, Igor; Robert, Caroline; Salama,
April K; Sandhu, Shaneen; Schadendorf, Dirk; Shoushtari, Alexander N;
Sosman, Jeffrey A; Swetter, Susan M; Tanabe, Ken K; Turajlic, Samra;
Tyler, Douglas S; Woodman, Scott E; Wright, Frances C; Zager, Jonathan
S |
The Lancet Oncology |
2019 |
| 10296 |
10.1016/s1470-2045(19)30388-2 |
Pembrolizumab Versus Ipilimumab In Advanced Melanoma
(Keynote-006): Post-Hoc 5-Year Results From An Open-Label, Multicentre,
Randomised, Controlled, Phase 3 Study |
Robert, Caroline; Ribas, Antoni; Schachter, Jacob;
Arance, Ana; Grob, Jean-Jacques; Mortier, Laurent; Daud, Adil; Carlino,
Matteo S; Mcneil, Catriona M; Lotem, Michal; Larkin, James M G; Lorigan,
Paul; Neyns, Bart; Blank, Christian U; Petrella, Teresa M; Hamid, Omid;
Su, Shu-Chih; Krepler, Clemens; Ibrahim, Nageatte; Long, Georgina V |
The Lancet Oncology |
2019 |
| 10347 |
10.1016/s1470-2045(20)30494-0 |
Adjuvant Nivolumab Versus Ipilimumab In Resected Stage
Iiib<U+2013>C And Stage Iv Melanoma (Checkmate 238): 4-Year
Results From A Multicentre, Double-Blind, Randomised, Controlled, Phase
3 Trial |
Ascierto, Paolo A; Del Vecchio, Michele; Mandala,
Mario; Gogas, Helen; Arance, Ana M; Dalle, Stephane; Cowey, C Lance;
Schenker, Michael; Grob, Jean-Jacques; Chiarion-Sileni, Vanna;
Marquez-Rodas, Ivan; Butler, Marcus O; Maio, Michele; Middleton, Mark R;
De La Cruz-Merino, Luis; Arenberger, Petr; Atkinson, Victoria; Hill,
Andrew; Fecher, Leslie A; Millward, Michael; Khushalani, Nikhil I;
Queirolo, Paola; Lobo, Maurice; De Pril, Veerle; Loffredo, John; Larkin,
James; Weber, Jeffrey |
The Lancet Oncology |
2020 |
| 14656 |
10.1038/s41591-018-0197-1 |
Neoadjuvant Immune Checkpoint Blockade In High-Risk
Resectable Melanoma |
Amaria, Rodabe N., 0000-0001-6876-278X; Reddy,
Sangeetha M.; Tawbi, Hussein A.; Davies, Michael A.,
0000-0002-0977-0912; Ross, Merrick I.; Glitza, Isabella C.; Cormier,
Janice N.; Lewis, Carol; Hwu, Wen-Jen; Hanna, Ehab; Diab, Adi; Wong,
Michael K.; Royal, Richard; Gross, Neil, 0000-0002-9427-0743; Weber,
Randal; Lai, Stephen Y.; Ehlers, Richard; Blando, Jorge; Milton, Denai
R.; Woodman, Scott; Kageyama, Robin; Wells, Daniel K.; Hwu, Patrick;
Patel, Sapna P.; Lucci, Anthony; Hessel, Amy; Lee, Jeffrey E.;
Gershenwald, Jeffrey; Simpson, Lauren; Burton, Elizabeth M.; Posada,
Liberty; Haydu, Lauren; Wang, Linghua, 0000-0001-9380-0266; Zhang,
Shaojun; Lazar, Alexander J., 0000-0002-6395-4499; Hudgens, Courtney W.,
0000-0001-8312-7485; Gopalakrishnan, Vancheswaran; Reuben, Alexandre,
0000-0003-4510-0382; Andrews, Miles C.; Spencer, Christine N.; Prieto,
Victor; Sharma, Padmanee; Allison, James; Tetzlaff, Michael T.; Wargo,
Jennifer A. |
Nature Medicine |
2018 |
| 14657 |
10.1038/s41591-018-0198-0 |
Neoadjuvant Versus Adjuvant Ipilimumab Plus Nivolumab
In Macroscopic Stage Iii Melanoma |
Blank, Christian U.; Rozeman, Elisa A.; Fanchi, Lorenzo
F.; Sikorska, Karolina; Van De Wiel, Bart; Kvistborg, Pia; Krijgsman,
Oscar; Van Den Braber, Marlous; Philips, Daisy; Broeks, Annegien; Van
Thienen, Johannes V.; Mallo, Henk A.; Adriaansz, Sandra; Ter Meulen,
Sylvia; Pronk, Loes M.; Grijpink-Ongering, Lindsay G.; Bruining,
Annemarie; Gittelman, Rachel M.; Warren, Sarah; Van Tinteren, Harm;
Peeper, Daniel S.; Haanen, John B. A. G.; Van Akkooi, Alexander C. J.;
Schumacher, Ton N. |
Nature Medicine |
2018 |
| 14676 |
10.1038/s41591-019-0357-y |
A Single Dose Of Neoadjuvant Pd-1 Blockade Predicts
Clinical Outcomes In Resectable Melanoma |
|
Nature Medicine |
2019 |
| 14684 |
10.1038/s41591-019-0448-9 |
Dabrafenib, Trametinib And Pembrolizumab Or Placebo In
Braf-Mutant Melanoma |
Ascierto, Paolo Antonio, 0000-0002-8322-475X; Ferrucci,
Pier Francesco; Fisher, Rosalie; Del Vecchio, Michele; Atkinson,
Victoria; Schmidt, Henrik; Schachter, Jacob; Queirolo, Paola; Long,
Georgina V., 0000-0001-8894-3545; Di Giacomo, Anna Maria; Svane, Inge
Marie; Lotem, Michal; Bar-Sela, Gil; Couture, Felix; Mookerjee,
Bijoyesh; Ghori, Razi; Ibrahim, Nageatte; Moreno, Blanca Homet; Ribas,
Antoni, 0000-0003-3669-8458 |
Nature Medicine |
2019 |
| 14686 |
10.1038/s41591-019-0474-7 |
Atezolizumab Plus Cobimetinib And Vemurafenib In
Braf-Mutated Melanoma Patients |
Sullivan, Ryan J., 0000-0001-5344-6645; Hamid, Omid;
Gonzalez, Rene; Infante, Jeffrey R.; Patel, Manish R.; Hodi, F. Stephen;
Lewis, Karl D.; Tawbi, Hussein A.; Hernandez, Genevive; Wongchenko,
Matthew J., 0000-0003-1230-7117; Chang, Yimeng; Roberts, Louise;
Ballinger, Marcus; Yan, Yibing; Cha, Edward; Hwu, Patrick |
Nature Medicine |
2019 |
| 14687 |
10.1038/s41591-019-0476-5 |
Combined Braf And Mek Inhibition With Pd-1 Blockade
Immunotherapy In Braf-Mutant Melanoma |
Ribas, Antoni, 0000-0003-3669-8458; Lawrence, Donald;
Atkinson, Victoria; Agarwal, Sachin; Miller, Wilson H.; Carlino, Matteo
S.; Fisher, Rosalie; Long, Georgina V., 0000-0001-8894-3545; Hodi, F.
Stephen; Tsoi, Jennifer; Grasso, Catherine S.; Mookerjee, Bijoyesh;
Zhao, Qing; Ghori, Razi; Moreno, Blanca Homet; Ibrahim, Nageatte; Hamid,
Omid |
Nature Medicine |
2019 |
| 16056 |
10.1056/nejmoa1802357 |
Adjuvant Pembrolizumab Versus Placebo In Resected Stage
Iii Melanoma |
Eggermont, Alexander M.M.; Blank, Christian U.;
Mandala, Mario; Long, Georgina V., 0000-0001-8894-3545; Atkinson,
Victoria; Dalle, Stephane; Haydon, Andrew; Lichinitser, Mikhail;
Khattak, Adnan; Carlino, Matteo S.; Sandhu, Shahneen; Larkin, James;
Puig, Susana; Ascierto, Paolo A.; Rutkowski, Piotr; Schadendorf, Dirk;
Koornstra, Rutger; Hernandez-Aya, Leonel; Maio, Michele; Van Den
Eertwegh, Alfonsus J.M.; Grob, Jean-Jacques; Gutzmer, Ralf; Jamal,
Rahima; Lorigan, Paul; Ibrahim, Nageatte; Marreaud, Sandrine; Van
Akkooi, Alexander C.J.; Suciu, Stefan; Robert, Caroline |
New England Journal Of Medicine |
2018 |
| 16116 |
10.1056/nejmoa1904059 |
Five-Year Outcomes With Dabrafenib Plus Trametinib In
Metastatic Melanoma |
Robert, Caroline; Grob, Jean J.; Stroyakovskiy, Daniil;
Karaszewska, Boguslawa; Hauschild, Axel; Levchenko, Evgeny; Chiarion
Sileni, Vanna; Schachter, Jacob; Garbe, Claus; Bondarenko, Igor; Gogas,
Helen; Mandala, Mario; Haanen, John B.A.G.; Lebbe, Celeste; Mackiewicz,
Andrzej; Rutkowski, Piotr; Nathan, Paul D.; Ribas, Antoni; Davies,
Michael A.; Flaherty, Keith T.; Burgess, Paul; Tan, Monique; Gasal,
Eduard; Voi, Maurizio; Schadendorf, Dirk; Long, Georgina V. |
New England Journal Of Medicine |
2019 |
| 16136 |
10.1056/nejmoa1910836 |
Five-Year Survival With Combined Nivolumab And
Ipilimumab In Advanced Melanoma |
Larkin, James; Chiarion-Sileni, Vanna; Gonzalez, Rene;
Grob, Jean-Jacques; Rutkowski, Piotr; Lao, Christopher D.; Cowey, C.
Lance; Schadendorf, Dirk; Wagstaff, John; Dummer, Reinhard; Ferrucci,
Pier F.; Smylie, Michael; Hogg, David; Hill, Andrew; Marquez-Rodas,
Ivan; Haanen, John; Guidoboni, Massimo; Maio, Michele; Schoffski,
Patrick; Carlino, Matteo S.; Lebbe, Celeste; Mcarthur, Grant; Ascierto,
Paolo A.; Daniels, Gregory A.; Long, Georgina V., 0000-0001-8894-3545;
Bastholt, Lars; Rizzo, Jasmine I.; Balogh, Agnes; Moshyk, Andriy; Hodi,
F. Stephen; Wolchok, Jedd D. |
New England Journal Of Medicine |
2019 |
| 16175 |
10.1056/nejmoa2005493 |
Five-Year Analysis Of Adjuvant Dabrafenib Plus
Trametinib In Stage Iii Melanoma |
Dummer, Reinhard; Hauschild, Axel; Santinami, Mario;
Atkinson, Victoria; Mandala, Mario; Kirkwood, John M.; Chiarion Sileni,
Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew;
Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry;
Plummer, Ruth; Dasgupta, Kohinoor; Gasal, Eduard; Tan, Monique; Long,
Georgina V.; Schadendorf, Dirk, 0000-0003-3524-7858 |
New England Journal Of Medicine |
2020 |
| 16972 |
10.1093/annonc/mdz011 |
Five-Year Survival Outcomes For Patients With Advanced
Melanoma Treated With Pembrolizumab In Keynote-001 |
Hamid, O.; Robert, C.; Daud, A.; Hodi, F.S.; Hwu, W.J.;
Kefford, R.; Wolchok, J.D.; Hersey, P.; Joseph, R.; Weber, J.S.; Dronca,
R.; Mitchell, T.C.; Patnaik, A.; Zarour, H.M.; Joshua, A.M.; Zhao, Q.;
Jensen, E.; Ahsan, S.; Ibrahim, N.; Ribas, A. |
Annals Of Oncology |
2019 |
| 16978 |
10.1093/annonc/mdz110 |
Discontinuation Of Anti-Pd-1 Antibody Therapy In The
Absence Of Disease Progression Or Treatment Limiting Toxicity: Clinical
Outcomes In Advanced Melanoma |
Jansen, Y.J.L.; Rozeman, E.A.; Mason, R.,
0000-0001-8055-9936; Goldinger, S.M.; Geukes Foppen, M.H.; Hoejberg, L.;
Schmidt, H.; Van Thienen, J.V.; Haanen, J.B.A.G.; Tiainen, L.; Svane,
I.M.; Makela, S.; Seremet, T.; Arance, A.; Dummer, R.; Bastholt, L.;
Nyakas, M.; Straume, O.; Menzies, A.M.; Long, G.V.; Atkinson, V.; Blank,
C.U.; Neyns, B. |
Annals Of Oncology |
2019 |
| 20193 |
10.1186/s40425-019-0579-z |
Real-World Efficacy And Safety Of Nivolumab In
Previously-Treated Metastatic Renal Cell Carcinoma, And Association
Between Immune-Related Adverse Events And Survival: The Italian Expanded
Access Program |
Verzoni, Elena; Carteni, Giacomo; Cortesi, Enrico;
Giannarelli, Diana; De Giglio, Andrea; Sabbatini, Roberto; Buti,
Sebastiano; Rossetti, Sabrina; Cognetti, Francesco; Rastelli, Francesca;
Sobrero, Alberto; Turci, Daniele; Sternberg, Cora N.; Porta, Camillo;
Cappuzzo, Federico; Tortora, Giampaolo; Tassinari, Davide; Panni,
Stefano; Pazzola, Antonio; Surico, Gianmarco; Raimondi, Alessandra; De
Giorgi, Ugo; Procopio, Giuseppe |
Journal For Immunotherapy Of Cancer |
2019 |
| 20223 |
10.1200/jco.18.01219 |
Longer Follow-Up Confirms Relapse-Free Survival Benefit
With Adjuvant Dabrafenib Plus Trametinib In Patients With Resected Braf
V600<U+2013>Mutant Stage Iii Melanoma |
Hauschild, Axel; Dummer, Reinhard; Schadendorf, Dirk;
Santinami, Mario; Atkinson, Victoria; Mandala, Mario; Chiarion-Sileni,
Vanna; Larkin, James; Nyakas, Marta; Dutriaux, Caroline; Haydon, Andrew;
Robert, Caroline; Mortier, Laurent; Schachter, Jacob; Lesimple, Thierry;
Plummer, Ruth; Dasgupta, Kohinoor; Haas, Tomas; Shilkrut, Mark; Gasal,
Eduard; Kefford, Richard; Kirkwood, John M.; Long, Georgina V. |
Journal Of Clinical Oncology |
2018 |
| 20246 |
10.1200/jco.19.00318 |
Analysis Of The Association Between Adverse Events And
Outcome In Patients Receiving A Programmed Death Protein 1 Or Programmed
Death Ligand 1 Antibody |
Maher, V. Ellen; Fernandes, Laura L.; Weinstock, Chana;
Tang, Shenghui; Agarwal, Sundeep; Brave, Michael; Ning, Yang-Min; Singh,
Harpreet; Suzman, Daniel; Xu, James; Goldberg, Kirsten B.; Sridhara,
Rajeshwari; Ibrahim, Amna; Theoret, Marc; Beaver, Julia A.; Pazdur,
Richard |
Journal Of Clinical Oncology |
2019 |
| 20265 |
10.1200/jco.19.01464 |
Long-Term Outcomes And Responses To Retreatment In
Patients With Melanoma Treated With Pd-1 Blockade |
Betof Warner, Allison; Palmer, Jessica S.; Shoushtari,
Alexander N.; Goldman, Debra A.; Panageas, Katherine S.; Hayes, Sara A.;
Bajwa, Raazi; Momtaz, Parisa; Callahan, Margaret K.; Wolchok, Jedd D.;
Postow, Michael A.; Chapman, Paul B. |
Journal Of Clinical Oncology |
2020 |
| 20301 |
10.1200/jco.20.02110 |
Longer Follow-Up Confirms Recurrence-Free Survival
Benefit Of Adjuvant Pembrolizumab In High-Risk Stage Iii Melanoma:
Updated Results From The Eortc 1325-Mg/Keynote-054 Trial |
Eggermont, Alexander M. M.; Blank, Christian U.;
Mandala, Mario; Long, Georgina V., 0000-0001-8894-3545; Atkinson,
Victoria G.; Dalle, Stephane; Haydon, Andrew M.; Meshcheryakov, Andrey,
0000-0002-6009-653X; Khattak, Adnan; Carlino, Matteo S.; Sandhu,
Shahneen; Larkin, James, 0000-0001-5569-9523; Puig, Susana; Ascierto,
Paolo A., 0000-0002-8322-475X; Rutkowski, Piotr; Schadendorf, Dirk,
0000-0003-3524-7858; Koornstra, Rutger; Hernandez-Aya, Leonel; Di
Giacomo, Anna Maria; Van Den Eertwegh, Alfonsus J. M.; Grob,
Jean-Jacques, 0000-0002-0667-153X; Gutzmer, Ralf, 0000-0001-7921-2820;
Jamal, Rahima; Lorigan, Paul C., 0000-0002-8875-2164; Van Akkooi,
Alexander C. J.; Krepler, Clemens; Ibrahim, Nageatte,
0000-0003-0794-949X; Marreaud, Sandrine; Kicinski, Michal; Suciu,
Stefan, 0000-0003-3281-8256; Robert, Caroline, 0000-0002-9493-0238 |
Journal Of Clinical Oncology |
2020 |
| 20304 |
10.1200/jco.2017.75.6270 |
Durable Complete Response After Discontinuation Of
Pembrolizumab In Patients With Metastatic Melanoma |
Robert, Caroline; Ribas, Antoni; Hamid, Omid; Daud,
Adil; Wolchok, Jedd D.; Joshua, Anthony M.; Hwu, Wen-Jen; Weber, Jeffrey
S.; Gangadhar, Tara C.; Joseph, Richard W.; Dronca, Roxana; Patnaik,
Amita; Zarour, Hassane; Kefford, Richard; Hersey, Peter; Zhang, Jin;
Anderson, James; Diede, Scott J.; Ebbinghaus, Scot; Hodi, F.
Stephen |
Journal Of Clinical Oncology |
2018 |